Cesium decorporation

NU02 Cesium decorporation 137Cs is gamma and beta emitting by-product of uranium

Learn more

AONYS drug delivery technology

AONYS® is a mix of lipidic components that spontaneously assemble into a water-in-oil

Learn more

Drug to treat neurodegenerative diseases

NP03 is a disease-modifying nano dose formulation of lithium citrate in an AONYS®

Learn more

Pipeline

Guidelines for classical drug development, Guidelines “Animal Rules” and Research

Learn more

Nuclear radioprotection drug

The objective of the radioprotection program is to develop a radiomitigation drug,

Learn more

Nuclear decorporation drugs – Plutonium decorporation

NU01 Plutonium decorporation Plutonium (Pu) is an alpha emitting radionuclide which

Learn more

Alzheimer’s disease

Alzheimer’s disease is the most frequent cause of dementia and one of the most

Learn more

Huntington’s disease

Huntington’s Disease (HD) is a fatal autosomal dominant progressive neurodegenerative

Learn more

Drug to treat type 2 diabetes

Sed maximum est in amicitia parem esse inferiori. Saepe enim excellentiae quaedam

Learn more

Drugs for the protection of populations exposed to a nuclear accident

After a civil or military accident, involving nuclear material, dispersed radioactive

Learn more